Home » Health » THC in Driver Blood: Study Shows High Levels Despite Legalization

THC in Driver Blood: Study Shows High Levels Despite Legalization

Study Reveals High THC Presence in ​Drivers Involved in Fatal Crashes,Legalization Shows No Impact

A new​ study examining drivers involved in fatal motor vehicle collisions in​ Montgomery County,Ohio,found that nearly 42% tested positive​ for active delta-9-tetrahydrocannabinol‍ (THC),the psychoactive component of⁣ cannabis. The research, analyzing coroner records from January 2019⁢ to September 2024 across ⁢246 deceased ⁢drivers, revealed an average⁣ THC​ blood level of 30.7 ng/mL – significantly higher ‍than the legal impairment limits set by ⁤most ‍states, which​ typically range from 2 ​to 5‍ ng/mL.

Researchers, led‌ by Akpofure P. Ekeh,MBBS,FACS,of Wright State⁤ University,observed consistent THC positivity rates ranging from 25.7% to 48.9% annually throughout the six-year study period. Notably,the legalization of recreational cannabis⁤ in ⁤Ohio in 2023 did not demonstrably alter the‌ prevalence of THC detection in deceased drivers;⁣ rates ⁣were 42.1% ​before ​legalization and 45.2% after.

“The average ‍THC level we ⁤observed suggests recent marijuana consumption prior to driving, not simply residual ​presence in the system,” explained Dr. Ekeh.

The study emphasizes a ‍continuing public ⁢health concern, with ⁢authors advocating for strengthened messaging regarding the risks of driving under the ​influence of cannabis. They ⁤suggest treating cannabis impairment with the same seriousness as alcohol impairment.

The research was accepted for ⁢presentation at the American College of Surgeons (ACS) clinical Congress 2025, October 4-7 in Chicago.

Study Contributors: ​Lois Nguapa, BS; Clara Mussin Phillips, ‍BS; and ann Cardosi, ⁤BS, MPH.

Citation: Ekeh A, et ​al. Cannabis Prevalence in Drivers Involved‍ in ⁤Motor vehicle Crash Fatalities over a 6-Year period, Scientific Forum, American College of Surgeons (ACS) Clinical Congress 2025.

Vital Note: This research⁣ was presented ‍as an abstract at the ACS Clinical Congress Scientific Forum. ‍Research abstracts presented at the ACS Clinical ⁢Congress Scientific Forum are reviewed and selected by a program committee but are not yet peer reviewed.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.